Seishin Azuma

1.5k citations

37 papers · 930 indexed · h-index 17

Co-authors: Mamoru Watanabe Mina Nakagawa Sei Kakinuma Yasuhiro Itsui Naoya Sakamoto Sayuri Nitta Miyako Murakawa Yuki Nishimura‐Sakurai
Topics: Hepatitis C virus research (25 papers)Liver Disease Diagnosis and Treatment (12 papers)Hepatitis B Virus Studies (12 papers)
Cited by: Hepatology Epidemiology Immunology
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Hepatology
Partner nations: Japan United States France

In The Last Decade

Seishin Azuma

34 papers receiving 922 citations

Peers

Countries citing papers authored by Seishin Azuma

Since Specialization

Citations

This map shows the geographic impact of Seishin Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seishin Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seishin Azuma more than expected).

Fields of papers citing papers by Seishin Azuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seishin Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seishin Azuma. The network helps show where Seishin Azuma may publish in the future.

Co-authorship network of co-authors of Seishin Azuma

This figure shows the co-authorship network connecting the top 25 collaborators of Seishin Azuma. A scholar is included among the top collaborators of Seishin Azuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seishin Azuma. Seishin Azuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades 2024 ·PLoS ONE ·Shun Kaneko,Yasuhiro Asahina,Miyako Murakawa,Seishin Azuma,Kento Inada,(unknown),(unknown),Taro Shimizu,Jun Tsuchiya,Masato Miyoshi,Fukiko Kawai‐Kitahata,Sayuri Nitta,(unknown),Tomoyuki Fujioka,Mitsuhiro Kishino,Tatsuhiko Anzai,Sei Kakinuma,Mina Nakagawa,Ryuichi Okamoto	0
2	Clinical outcomes of endoscopic detachable snare ligation for colonic diverticular hemorrhage: Multicenter cohort study 2024 ·Digestive Endoscopy ·Katsumasa Kobayashi,(unknown),(unknown),(unknown),(unknown),Ryohei Kobayashi,(unknown),(unknown),Katsuhiro Arai,(unknown),(unknown),Ayako Sato,(unknown),Taichi Matsumoto,Toru Asano,(unknown),Seishin Azuma	2
3	COVID-19 pneumonia complicated by bilateral pneumothorax: A case report 2020 ·Respiratory Medicine Case Reports ·(unknown),(unknown),(unknown),Tsukasa Okamoto,(unknown),(unknown),(unknown),Junichi Takahashi,Seishin Azuma,(unknown),Hirokazu Sasaki,(unknown),(unknown),(unknown),Koji Morishita,Junichi Aiboshi,Yasuhiro Otomo,Yasunari Miyazaki	4
4	Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs 2020 ·Journal of Gastroenterology ·Mina Nakagawa,Nobutoshi Nawa,(unknown),Taro Shimizu,Jun Tsuchiya,Ayako Sato,Masato Miyoshi,Fukiko Kawai‐Kitahata,Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Takeo Fujiwara,Mamoru Watanabe,Yujiro Tanaka,Yasuhiro Asahina,(unknown)	19
5	Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients 2019 ·Scientific Reports ·Sayuri Nitta,Yasuhiro Asahina,Takanobu Kato,Jun Tsuchiya,(unknown),Ayako Sato,Tomoyuki Tsunoda,Masato Miyoshi,Fukiko Kawai‐Kitahata,Miyako Murakawa,Yasuhiro Itsui,Mina Nakagawa,Seishin Azuma,Sei Kakinuma,Hayato Hikita,Tetsuo Takehara,Mamoru Watanabe	11
6	LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells 2019 ·Scientific Reports ·Masato Miyoshi,Sei Kakinuma,Akihide Kamiya,Tomoyuki Tsunoda,Jun Tsuchiya,Ayako Sato,Shun Kaneko,Sayuri Nitta,Fukiko Kawai‐Kitahata,Miyako Murakawa,Yasuhiro Itsui,Mina Nakagawa,Seishin Azuma,Hiromitsu Nakauchi,Yasuhiro Asahina,Mamoru Watanabe	19
7	Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 2019 ·Digestive Diseases ·Seishin Azuma,Yasuhiro Asahina,Sei Kakinuma,Keiko Azuma,Masato Miyoshi,Emi Inoue,Tomoyuki Tsunoda,Ayako Sato,Shun Kaneko,Hiroko Nagata,Fukiko Kawai‐Kitahata,Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Makoto Tomita,Mina Nakagawa,Mamoru Watanabe	15
8	Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C 2017 ·Journal of Hepatology ·Hiroko Nagata,Mina Nakagawa,Yasuhiro Asahina,Ayako Sato,Yu Asano,Tomoyuki Tsunoda,Masato Miyoshi,Shun Kaneko,Satoshi Otani,Fukiko Kawai‐Kitahata,Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Toshihiko Nouchi,Hideki Sakai,Makoto Tomita,Mamoru Watanabe	139
9	Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy 2016 ·Hepatology International ·(unknown),Hiroko Nagata,Mina Nakagawa,Yuki Nishimura‐Sakurai,Yu Asano,Tomoyuki Tsunoda,Masato Miyoshi,Shun Kaneko,Fumio Goto,Satoshi Otani,(unknown),Miyako Murakawa,Sayuri Nitta,Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Naoko Tojo,Shuji Tohda,Yasuhiro Asahina,Mamoru Watanabe	52
10	Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule 2014 ·Clinical Journal of Gastroenterology ·Yoshihito Kano,Sei Kakinuma,Fumio Goto,Seishin Azuma,Yuki Nishimura‐Sakurai,Yasuhiro Itsui,Mina Nakagawa,Atsushi Kudo,Minoru Tanabe,Susumu Kirimura,(unknown),Takashi Ito,Takumi Akashi,Yasuhiro Asahina,Mamoru Watanabe	11
11	Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice 2013 ·Hepatology ·(unknown),Sei Kakinuma,Akihide Kamiya,Naoya Sakamoto,Sayuri Nitta,(unknown),(unknown),(unknown),Miyako Murakawa,(unknown),Hiromichi Shimizu,Ryuichi Okamoto,Seishin Azuma,Mina Nakagawa,Yasuhiro Asahina,Naoki Tanimizu,Akira Kikuchi,Hiromitsu Nakauchi,Mamoru Watanabe	27
12	Hepatitis C virus NS4B protein targets STING and abrogates RIG-I–mediated type I interferon-dependent innate immunity 2012 ·Hepatology ·Sayuri Nitta,Naoya Sakamoto,Mina Nakagawa,Sei Kakinuma,(unknown),(unknown),(unknown),Miyako Murakawa,Yuki Nishimura‐Sakurai,Seishin Azuma,Megumi Tasaka‐Fujita,Yasuhiro Asahina,Mitsutoshi Yoneyama,Takashi Fujita,Mamoru Watanabe	124
13	Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C 2012 ·Hepatology International ·(unknown),Mina Nakagawa,Naoya Sakamoto,Takako Watanabe,Yuki Nishimura‐Sakurai,(unknown),Seishin Azuma,Sei Kakinuma,Sayuri Nitta,(unknown),(unknown),Miyako Murakawa,(unknown),Yasuhiro Itsui,Yasuhito Tanaka,Masashi Mizokami,Mamoru Watanabe	2
14	Studies on virus kinetics using infectious fluorescence‐tagged hepatitis C virus cell culture 2011 ·Hepatology Research ·(unknown),Naoya Sakamoto,Tetsuya Nakamura,Yasuhiro Itsui,Mina Nakagawa,Yuki Nishimura‐Sakurai,Sei Kakinuma,Seishin Azuma,Kiichiro Tsuchiya,Takanobu Kato,Takaji Wakita,Mamoru Watanabe	4
15	Association of IL28B variants with response to pegylated‐interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b 2011 ·Journal of Medical Virology ·Naoya Sakamoto,Mina Nakagawa,Yasuhito Tanaka,Yuko Sekine‐Osajima,Mayumi Ueyama,Masayuki Kurosaki,Nao Nishida,Akihiro Tamori,(unknown),Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Shuhei Hige,Yoshito Itoh,Eiji Tanaka,Yoichi Hiasa,Namiki Izumi,Katsushi Tokunaga,Masashi Mizokami,Mamoru Watanabe,(unknown)	40
16	Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants 2010 ·Virology ·(unknown),Naoya Sakamoto,Yuko Sekine‐Osajima,Mina Nakagawa,Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,(unknown),(unknown),Kiichiro Tsuchiya,Michio Imamura,Nobuhiko Hiraga,Kazuaki Chayama,Takaji Wakita,Mamoru Watanabe	18
17	ITPA gene variant protects against anemia induced by pegylated interferon‐α and ribavirin therapy for Japanese patients with chronic hepatitis C 2010 ·Hepatology Research ·Naoya Sakamoto,Yasuhito Tanaka,Mina Nakagawa,Hiroshi Yatsuhashi,Shuhei Nishiguchi,Nobuyuki Enomoto,Seishin Azuma,Yuki Nishimura‐Sakurai,Sei Kakinuma,Nao Nishida,Katsushi Tokunaga,Masao Honda,Kiyoaki Ito,Masashi Mizokami,Mamoru Watanabe	57
18	IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones 2010 ·Virology ·Goki Suda,Naoya Sakamoto,Yasuhiro Itsui,Mina Nakagawa,Megumi Tasaka‐Fujita,(unknown),Takako Watanabe,Sayuri Nitta,(unknown),Seishin Azuma,Sei Kakinuma,Kiichiro Tsuchiya,Michio Imamura,Nobuhiko Hiraga,Kazuaki Chayama,Mamoru Watanabe	19
19	Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection 2010 ·Journal of Gastroenterology ·Mina Nakagawa,Naoya Sakamoto,Mayumi Ueyama,Kaoru Mogushi,(unknown),Yasuhiro Itsui,Seishin Azuma,Sei Kakinuma,Hiroshi Tanaka,Nobuyuki Enomoto,Mamoru Watanabe	22
20	Antiviral effects of the interferon‐induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein† 2009 ·Hepatology ·Yasuhiro Itsui,Naoya Sakamoto,Sei Kakinuma,Mina Nakagawa,Yuko Sekine‐Osajima,Megumi Tasaka‐Fujita,Yuki Nishimura‐Sakurai,(unknown),(unknown),(unknown),(unknown),Takako Watanabe,Mayumi Ueyama,(unknown),Seishin Azuma,Mamoru Watanabe	131

About Seishin Azuma

Seishin Azuma is a scholar working on Hepatology, Epidemiology and Rheumatology, having authored 37 papers that have together received 930 indexed citations. Recurring topics across this work include Hepatitis C virus research (25 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (12 papers). The work is most often cited by research in Hepatology (589 citations), Epidemiology (495 citations) and Immunology (233 citations). Seishin Azuma has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Mamoru Watanabe, Mina Nakagawa, Sei Kakinuma, Yasuhiro Itsui, Naoya Sakamoto, Sayuri Nitta, Miyako Murakawa, Yuki Nishimura‐Sakurai, Yasuhiro Asahina and Megumi Tasaka‐Fujita. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact